标题
PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s
作者
关键词
PPAR gamma, PGC-1 alpha, Parkinson’s disease, Neuroprotection
出版物
NEUROCHEMICAL RESEARCH
Volume 40, Issue 2, Pages 308-316
出版商
Springer Nature
发表日期
2014-07-09
DOI
10.1007/s11064-014-1377-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PPARγ activation rescues mitochondrial function from inhibition of complex I and loss of PINK1
- (2014) Juan Carlos Corona et al. EXPERIMENTAL NEUROLOGY
- Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR-γAgonist against MPTP
- (2013) Christine R. Swanson et al. PPAR Research
- PGC-1α: a master gene that is hard to master
- (2012) Dan Lindholm et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's disease
- (2012) Heather L. Martin et al. EXPERIMENTAL NEUROLOGY
- Sustained expression of PGC-1 in the rat nigrostriatal system selectively impairs dopaminergic function
- (2012) C. Ciron et al. HUMAN MOLECULAR GENETICS
- Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease
- (2012) C. Laloux et al. PHARMACOLOGICAL RESEARCH
- Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats
- (2012) Eun Young Lee et al. TOXICOLOGY LETTERS
- Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease
- (2011) Gokhan K. Ulusoy et al. BRAIN RESEARCH BULLETIN
- PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
- (2011) Joo-Ho Shin et al. CELL
- Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease
- (2011) Giuseppa Mudò et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
- (2011) Christine R Swanson et al. Journal of Neuroinflammation
- Mitochondrial Parkin Recruitment Is Impaired in Neurons Derived from Mutant PINK1 Induced Pluripotent Stem Cells
- (2011) P. Seibler et al. JOURNAL OF NEUROSCIENCE
- Telomere dysfunction induces metabolic and mitochondrial compromise
- (2011) Ergün Sahin et al. NATURE
- Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model
- (2011) A.R. Carta et al. NEUROSCIENCE
- Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepatocyte
- (2011) Xin Wang et al. TOXICOLOGY IN VITRO
- Reduced expression of peroxisome-proliferator activated receptor gamma coactivator-1α enhances α-synuclein oligomerization and down regulates AKT/GSK3β signaling pathway in human neuronal cells that inducibly express α-synuclein
- (2010) Abdul Shukkur Ebrahim et al. NEUROSCIENCE LETTERS
- PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
- (2010) B. Zheng et al. Science Translational Medicine
- PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson’s disease
- (2009) Nicoletta Schintu et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- PGC-1α and PGC-1β Regulate Mitochondrial Density in Neurons
- (2009) Przemyslaw Wareski et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SUMOylation Attenuates the Function of PGC-1α
- (2009) Miia M. Rytinki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nrf2 activators provide neuroprotection against 6-hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures
- (2009) Aubrey Siebert et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Nrf2 signaling and cell survival
- (2009) Suryakant K. Niture et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The PPARγ agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B
- (2008) L P Quinn et al. BRITISH JOURNAL OF PHARMACOLOGY
- Emerging pathways in genetic Parkinson’s disease: Autosomal-recessive genes in Parkinson’s disease - a common pathway?
- (2008) Julia C. Fitzgerald et al. FEBS Journal
- PPAR: a therapeutic target in Parkinsons disease
- (2008) Rajnish K. Chaturvedi et al. JOURNAL OF NEUROCHEMISTRY
- Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt
- (2008) Bin Xing et al. Journal of Neuroinflammation
- Complete Rescue of Cerebrovascular Function in Aged Alzheimer's Disease Transgenic Mice by Antioxidants and Pioglitazone, a Peroxisome Proliferator-Activated Receptor Agonist
- (2008) N. Nicolakakis et al. JOURNAL OF NEUROSCIENCE
- Mitochondria in the aetiology and pathogenesis of Parkinson's disease
- (2008) Anthony HV Schapira LANCET NEUROLOGY
- PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease
- (2008) Gary Landreth et al. Neurotherapeutics
- Review of the expression of peroxisome proliferator-activated receptors alpha (PPARα), beta (PPARβ), and gamma (PPARγ) in rodent and human development
- (2008) Barbara D. Abbott REPRODUCTIVE TOXICOLOGY
- Neurobiology and treatment of Parkinson's disease
- (2008) Anthony H.V. Schapira TRENDS IN PHARMACOLOGICAL SCIENCES
- Regulation of Glial Cell Functions by PPAR- Natural and Synthetic Agonists
- (2008) Antonietta Bernardo et al. PPAR Research
- Interleukin-4 mediates the neuroprotective effects of rosiglitazone in the aged brain
- (2007) David J. Loane et al. NEUROBIOLOGY OF AGING
- Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague–Dawley rats
- (2007) Randy L. Hunter et al. NEUROSCIENCE LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started